Search alternatives:
significantly observed » significantly bolstered (Expand Search), significantly altered (Expand Search), significantly clustered (Expand Search)
decrease » decreased (Expand Search), increase (Expand Search)
significantly observed » significantly bolstered (Expand Search), significantly altered (Expand Search), significantly clustered (Expand Search)
decrease » decreased (Expand Search), increase (Expand Search)
-
2121
Effects of berry consumption on cardiometabolic risk factors in patients with metabolic syndrome: a systematic review and meta-analysis of randomised controlled trials
Published 2025“…The subgroup analysis showed that interventions <12 weeks resulted in a significant increase in HDL-C levels and a significant decrease in serum TG levels. …”
-
2122
Table 6_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2123
Image 1_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2124
Table 1_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2125
Image 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2126
Table 7_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2127
Table 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2128
Table 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2129
Table 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2130
Image 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2131
Image 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2132
Table 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2133
Table 9_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2134
Table 8_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2135
Image 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
2136
Table 1_Nutritionally adequate, healthy, and climate-friendly diets following the Nordic Nutrition Recommendations 2023: an optimization study for Norway.xlsx
Published 2025“…Regardless of degree of environmental impact reduction, diets following NNR2023 guidelines will require significant dietary changes compared to observed intake, including an increase in consumption of fruits, vegetables, and grains, and a strong decrease in consumption of red meat, total meat, and discretionary foods. …”
-
2137
Image 1_A randomized study on the effect of a wearable device using 0.75 Hz transcranial electrical stimulation on sleep onset insomnia.tif
Published 2024“…No order effects were observed with 0.75Hz stimulation. The decrease in SOL with 0.75Hz treatment was proportional to an individual’s baseline wherein those suffering from the longest pre-treated SOLs realized the greatest benefits. …”
-
2138
Data Sheet 1_A randomized study on the effect of a wearable device using 0.75 Hz transcranial electrical stimulation on sleep onset insomnia.docx
Published 2024“…No order effects were observed with 0.75Hz stimulation. The decrease in SOL with 0.75Hz treatment was proportional to an individual’s baseline wherein those suffering from the longest pre-treated SOLs realized the greatest benefits. …”
-
2139
Table 1_Genomic and phenotypic characterization of two novel human-derived Limosilactobacillus reuteri strains with unique probiotic traits.docx
Published 2025“…In co-culture with LS174T cells, both strains decrease the production of Mucin-2, a key component of the gut barrier, with LLR2 showing significantly greater efficacy. …”
-
2140
Supplementary Material for: Cabergoline’s Promise in Endometriosis: Restoring Molecular Balance to Improve Reproductive Potential
Published 2025“…Results: Cabergoline treatment reduced the expression levels of VEGFR-2, FAK, PXN, ITGB3, and ITGAV, with ITGAV showing a statistically significant decrease (p = 0.0174). Hypomethylation of the VEGFR-2 promoter was observed in the treatment group (p = 0.3566). …”